Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Monika Herrmann, Christina Krupka, Katrin Deiser, Bettina Brauchle, Anetta Marcinek, Ana Ogrinc Wagner, Felicitas Rataj, Ralph Mocikat, Klaus H. Metzeler, Karsten Spiekermann, Sebastian Kobold, Nadja C. Fenn, Karl-Peter Hopfner, Marion Subklewe

Blood (2018) 132 (23): 2484–2494.

https://doi.org/10.1182/blood-2018-05-849802

Published: 2018

Includes: Supplemental data

Journal Articles

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Monika Herrmann, PhD, Christina Krupka, PhD, Katrin Deiser, PhD, Bettina Lindl, Ralph Mocikat, MD, Klaus H. Metzeler, MD, Karsten Spiekermann, MD, Sebastian Kobold, MD, Nadja Fenn, PhD, Karl-Peter Hopfner, PhD, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 4069.

https://doi.org/10.1182/blood-2018-99-119624

Published: 2018

Journal Articles

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

Alexandra Ziegler, Regina Heidenreich, Heidi Braumüller, Hartwig Wolburg, Susanne Weidemann, Ralph Mocikat, Martin Röcken

Blood (2009) 113 (15): 3494–3502.

https://doi.org/10.1182/blood-2008-08-175109

Published: 2009

Includes: Supplemental data

Journal Articles

DC-NK cell cross talk as a novel CD4 + T-cell–independent pathway for antitumor CTL induction

Christian Adam, Susan King, Thomas Allgeier, Heidi Braumüller, Carolin Lüking, Josef Mysliwietz, Anja Kriegeskorte, Dirk H. Busch, Martin Röcken, Ralph Mocikat

Blood (2005) 106 (1): 338–344.

https://doi.org/10.1182/blood-2004-09-3775

Published: 2005

Journal Articles

Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells

Konrad Kronenberger, Andreas Dieckmann, Michael Selmayr, John Strehl, Ulrich Wahl, Horst Lindhofer, Georg Kraal, Ralph Mocikat

Blood (2002) 99 (4): 1327–1331.

https://doi.org/10.1182/blood.V99.4.1327

Published: 2002

NARROW

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

DC-NK cell cross talk as a novel CD4 + T-cell–independent pathway for antitumor CTL induction

Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells

Email alerts

ASH Publications

American Society of Hematology

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

DC-NK cell cross talk as a novel CD4 + T-cell–independent pathway for antitumor CTL induction

Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only